BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T130000
DTEND;TZID=America/New_York:20240301T140000
DTSTAMP:20260501T183615
CREATED:20240216T175420Z
LAST-MODIFIED:20240226T114105Z
UID:33333-1709298000-1709301600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 1\, 2024: Effect of an Intensive Food-as-Medicine Program on Health and Healthcare Use: Evidence From a Randomized Clinical Trial (Joseph Doyle\, PhD)
DESCRIPTION:Speaker: \nJoseph Doyle\, PhD\nErwin H. Schell Professor of Management and Applied Economics\nMIT Sloan School of Management \nTitle: Effect of an Intensive Food-as-Medicine Program on Health and Healthcare Use: Evidence From a Randomized Clinical Trial \nDate: Friday\, March 1\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/92959702719?pwd=YWxTSllkZE5paDVMYjZaV05LL0pEdz09 \nMeeting ID: 929 5970 2719 \nPasscode: 500052 \nOne tap mobile \n+13126266799\,\,92959702719#\,\,\,\,*500052# US (Chicago) \n+16468769923\,\,92959702719#\,\,\,\,*500052# US (New York) \nAudio Dial in Options \nUS:  +1 309 205 3325 US \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 929 5970 2719 \nPasscode: 500052
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-1-2024-effect-of-an-intensive-food-as-medicine-program-on-health-and-health-care-use-evidence-from-a-randomized-clinical-trial-joseph-doyle-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240308T130000
DTEND;TZID=America/New_York:20240308T140000
DTSTAMP:20260501T183615
CREATED:20240223T160139Z
LAST-MODIFIED:20240301T170756Z
UID:33417-1709902800-1709906400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 8\, 2024: Public-Private Partnerships in the Trustworthy Health AI Ecosystem (Michael Pencina\, PhD; Brian Anderson\, MD)
DESCRIPTION:Speakers: \nMichael Pencina\, PhD\nChief Data Scientist\, Duke Health\nProfessor of Biostatistics and Bioinformatics and Vice Dean for Data Science\, Duke University School of Medicine \nBrian Anderson\, MD\nCEO\, Coalition for Health AI \nTitle: Public-private Partnerships in the Trustworthy Health AI Ecosystem \nDate: Friday\, March 8\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/98815957236?pwd=ZXNManc3eGk0NWQwayttL3FBb3RnZz09 \nMeeting ID: 990 4030 1071 \nPasscode: 505704 \nOne Tap Mobile \n+13017158592\,\,99040301071#\,\,\,\,*505704# US \n+13052241968\,\, 99040301071#\,\,\,\,*505704# US\nFind your local number: https://duke.zoom.us/u/acEzZCxM5z \nAudio Dial in Options \nUS:  +1 309 205 3325 US \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 990 4030 1071 \nPasscode: 505704
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-8-2024-public-private-partnerships-in-the-trustworthy-health-ai-ecosystem-michael-pencina-phd-brian-anderson-md/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240315T130000
DTEND;TZID=America/New_York:20240315T140000
DTSTAMP:20260501T183615
CREATED:20240214T151819Z
LAST-MODIFIED:20240313T144452Z
UID:33305-1710507600-1710511200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 15\, 2024: The Effect of Antibiotic Choice on Renal Outcomes: The ACORN Trial (Edward Qian\, MD\, MSc)
DESCRIPTION:Speaker: \nEdward Qian\, MD\, MSc\nAssistant Professor of Medicine\nVanderbilt University Medical Center\nDivision of Pulmonary and Critical Care Medicine \nTitle: The Effect of Antibiotic Choice on Renal Outcomes: The ACORN Trial \nDate: Friday\, March 15\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/97453499746?pwd=bXRuaGQ3V2R3ZWJQdUJlSTZGNGo2dz09 \nMeeting ID: 974 5349 9746 \nPasscode: 885062 \n+13092053325\,\,97453499746#\,\,\,\,*885062# US \n+13052241968\,\, 97453499746#\,\,\,\,*885062# US\nFind your local number: https://duke.zoom.us/u/acEzZCxM5z \nAudio Dial in Options \nUS:  +1 309 205 3325 US \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 974 5349 9746 \nPasscode: 885062
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-15-2024-antibiotic-choice-on-renal-outcomes-the-acorn-trial-edward-qian-md-msc/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240320T120000
DTEND;TZID=America/New_York:20240320T130000
DTSTAMP:20260501T183615
CREATED:20240313T180739Z
LAST-MODIFIED:20240313T180739Z
UID:33526-1710936000-1710939600@rethinkingclinicaltrials.org
SUMMARY:Mind the Gap Webinar Series: Deconstruction of the Type 2 Hybrid Effectiveness-Implementation Study Design that Uses Two Randomized Controlled Trials
DESCRIPTION:Deconstruction of the Type 2 Hybrid Effectiveness-Implementation Study Design that Uses Two Randomized Controlled Trials\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister now \n\n\n\n\nPresented byJune Stevens\, Ph.D. \nMarch 20\, 202412:00 noon–1:00 p.m. ET\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbout the Webinar\nImplementation research addresses barriers to the successful conduct of interventions aimed at improving health. Thus\, implementation scientists are often interested in examining both the success of implementation strategies and health interventions. It can be argued that the most rigorous design to accomplish that goal would employ two randomized controlled trials—one testing implementation strategies on implementation outcomes and one testing an intervention on health-related outcomes. This type of study is called a dual randomized controlled trial (DRCT). Although the utility of the DRCT design is evident\, the limited literature review revealed that this design is rare in the published literature. \nThis webinar reviews the basic components of implementation-effectiveness studies. Dr. Stevens will then construct a paradigm that breaks down the components of the DRCT and provide a step-by-step explanation of features of the design and recommendations for use. The design includes a minimum of three randomized arms\, each comprised of an active or control implementation strategy paired with an active or control intervention. Examples are shown to demonstrate the use of the paradigm in different research settings. \nAbout June Stevens\nDr. June Stevens is an Epidemiologist at the University of North Carolina (UNC) at Chapel Hill with over 25 years of experience as the Principal Investigator (PI) of NIH-funded Coordinating Centers for multi-center trials that are community-based. Currently she is PI of the Research Coordinating Center for the Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Alliance\, which includes seven centers from around the country conducting implementation studies aimed at reducing disparities in cardiovascular risk. She has generated more than $32 million dollars in national-level grant funding as PI. \nDr. Stevens served as Chair of the Department of Nutrition at UNC during the years that the graduate program was given a No. 1 ranking by the National Research Council\, along with only three other Nutrition Departments in the United States. She has chaired NIH workshops and working groups tasked with recommending clinical guidelines. She is a recipient of the Lifetime Achievement Award from the Obesity Society and the Centrum Research Award for Senior Investigators from the American Society for Nutrition\, and holds a Distinguished Professorship from the American Institute for Cancer Research. She has been an invited expert for the World Health Organization\, the American Heart Association\, the Centers for Disease Control and Prevention\, and numerous NIH study sections. \n\n\n\n\n\n\n\n\n\n\n\n\n\nCan’t be there? A recording of this webinar will be available approximately 2 weeks after the session. You can view the full archive of previous Methods: Mind the Gap webinars on the Office of Disease Prevention website. \nThis event is open to the public and there will be an opportunity to ask questions at the end of the presentation. Please feel free to share this information widely. For more information\, please contact us at MindtheGap@nih.gov.
URL:https://rethinkingclinicaltrials.org/event/mind-the-gap-webinar-series-deconstruction-of-the-type-2-hybrid-effectiveness-implementation-study-design-that-uses-two-randomized-controlled-trials/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T130000
DTEND;TZID=America/New_York:20240322T140000
DTSTAMP:20260501T183615
CREATED:20240305T144443Z
LAST-MODIFIED:20240305T144443Z
UID:33468-1711112400-1711116000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 22\, 2024: Early Diagnosis and Assessment of Autism Via Objective Measurements of Social Visual Engagement (Warren Jones\, PhD)
DESCRIPTION:Speaker: \nWarren Jones\, PhD\nDirector of Research\, Marcus Autism Center\nChildren’s Healthcare of Atlanta\nNorman Nien Distinguished Chair in Autism\nAssociate Professor\, Dept. of Pediatrics\nEmory University School of Medicine \nTitle: Early Diagnosis and Assessment of Autism Via Objective Measurements of Social Visual Engagement \nDate: Friday\, March 22\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/91858520672?pwd=THNvc1hkWGtqcEppTnpWNEREK08rUT09 \nMeeting ID: 918 5852 0672 \nPasscode: 107909 \nOne Tap Mobile \n+16468769923\,\,91858520672#\,\,\,\,*107909# US \n+16469313860\,\,91858520672#\,\,\,\,*107909# US \nFind your local number: https://duke.zoom.us/u/acEzZCxM5z \nAudio Dial in Options \nUS:  +1 309 205 3325 US \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 918 5852 0672 \nPasscode: 107909
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-22-2024-early-diagnosis-and-assessment-of-autism-via-objective-measurements-of-social-visual-engagement-warren-jones-phd/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240327T130000
DTEND;TZID=America/New_York:20240327T140000
DTSTAMP:20260501T183615
CREATED:20240313T180559Z
LAST-MODIFIED:20240313T180559Z
UID:33524-1711544400-1711548000@rethinkingclinicaltrials.org
SUMMARY:Prevention in Focus Webinar Series: Is It More than PMS? Learn About PMDD
DESCRIPTION:Prevention in Focus Webinar Series: It More than PMS? Learn About PMDD\n\n\n\n\n\n\n\n\n\nMarybeth Bohn\, International Association for Premenstrual Disorders\n\n\n\n\n\n\n\n\nSandi MacDonald\, International Association for Premenstrual Disorders\n\n\n\n\n\n\n\nRegister for the webinar\n*A recording of this webinar will be available approximately two weeks after the session.\n\n\n\nAbout the Webinar\n\nMarybeth Bohn witnessed her 33-year-old daughter Christina’s suffering from a disorder that was frequently misdiagnosed\, and she often asked the inpatient psychiatrist\, “Where did my daughter go?” After nine months of her daughter being at home with her and her husband\, she finally figured out what was really happening when she learned about Premenstrual Dysphoric Disorder (PMDD). Right when hope was there and the sun was finally shining at the end of the tunnel\, she tragically lost her daughter to suicide due to PMDD. \nMs. Bohn will speak to the symptoms she and her husband witnessed as their daughter’s PMDD went undiagnosed and untreated for up to 15 years. The mask her daughter so effectively wore eventually slipped off\, and the symptoms took away the life Christina had worked so hard for. \nAlong with Ms. Bohn’s presentation\, Sandi MacDonald will discuss the diagnoses and symptoms of PMDD and Premenstrual Exacerbation (PME). She will also discuss the global impact of premenstrual disorders of Premenstrual Syndrome (PMS)\, PMDD\, and PME. \n\n\n\n\n\nAbout Marybeth Bohn\n\nMarybeth Bohn has been advocating for PMDD since she lost her daughter\, Christina Elizabeth Bohn\, to suicide in 2021 due to the disorder. The thought of others suffering as her daughter did for up to 15 years before receiving a correct diagnosis motivates Ms. Bohn to keep speaking out. She speaks publicly about PMDD to increase awareness and to reduce the time in getting an accurate diagnosis. She has spoken at the University of Missouri\, Postpartum Support International\, Missouri House of Representatives Committee on Healthcare Reform\, Women’s Mental Health Conference at Yale\, and many other venues. In 2023\, she worked with the Missouri Legislature to pass a bill for having an annual PMDD Awareness Day on Oct. 2\, which is Christina’s birthday. Ms. Bohn serves as Vice President of the Board of Directors for the International Association For Premenstrual Disorders (IAPMD) and has actively served as a PMDD Champion. After Christina’s death\, Ms. Bohn retired from the University of Missouri to focus on increasing awareness of PMDD. \n\n\n\n\n\nAbout Sandi MacDonald\n\nSandi MacDonald is the co-founder and executive director of IAPMD\, an organization she co-founded due to her lived experience with PMDD. The IAPMD is a scientific evidence-based organization that has reached over a million people. Ms. MacDonald has over 25 years of experience working in the mental health and addiction sectors. She has worked the front lines in these sectors and has taught college-level programs. She has created and implemented programming for many different projects\, including peer support programs utilized by people impacted by PMDD and other premenstrual disorders across the globe. \nAs the executive director of IAPMD\, she has managed several projects for the organization and has participated in many research projects. She has been published as a co-author in journals such as the Journal of International Medical Research\, JAMA\, and the Journal of Medical Internet Research. She helped manage and author a year-long research project that resulted in the first-ever PMDD roundtable event. This event and project resulted in two first-ever patient-centered resources\, “A Guide to Conducting Rigorous\, Patient-Centered PMDD Research” and “A Strategic Plan to Advance Patient-Centered PMDD Research.” \n\nThis webinar will be captioned in real time. Individuals needing reasonable accommodations should email PreventionInFocus@nih.gov. Requests should be made at least 5 business days before the event.
URL:https://rethinkingclinicaltrials.org/event/prevention-in-focus-webinar-series-is-it-more-than-pms-learn-about-pmdd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240329T130000
DTEND;TZID=America/New_York:20240329T140000
DTSTAMP:20260501T183615
CREATED:20240301T171027Z
LAST-MODIFIED:20240301T171027Z
UID:33451-1711717200-1711720800@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds March 29\, 2024: Effect Of A Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: A Pragmatic\, Cluster-Randomized Trial (Amit Garg\, MD\, MA\, FRCPC\, FACP\, PhD; Stephanie N. Dixon\, PhD\, MSc)
DESCRIPTION:Speakers: \nAmit Garg\, MD\, MA (Education) FRCPC\, FACP\, PhD\nAssociate Dean\, Clinical Research\, Schulich School of Medicine and Dentistry\nLead\, Institute for Clinical Evaluative Sciences Kidney\, Dialysis and Transplantation Provincial Program\nDirector\, Institute for Clinical Evaluative Sciences (ICES) Western Facility\nNephrologist\, London Health Sciences Centre\nProfessor\, Medicine\, Epidemiology & Biostatistics\, Western University  \nStephanie N. Dixon\, PhD MSc\nStaff Scientist\, Institute for Clinical Evaluative Sciences Kidney\, Dialysis and Transplantation Research Program\nBiostatistician\, London Health Sciences Centre \nTitle: Effect Of A Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: A Pragmatic\, Cluster-Randomized Trial \nDate: Friday\, March 29\, 2024\, 1:00-2:00 p.m. ET \nTo join the online meeting: \nClick the Zoom Meeting link below: \nhttps://duke.zoom.us/j/97048890491?pwd=ZnU1TmQ3UmpaU0RPTjdiT1kzWDZNdz09 \nMeeting ID: 970 4889 0491 \nPasscode: 101816 \nOne Tap Mobile \n+13052241968\,\,97048890491#\,\,\,\,*101816# US \n+13092053325\,\,97048890491#\,\,\,\,*101816# US\nFind your local number: https://duke.zoom.us/u/acEzZCxM5z \nAudio Dial in Options \nUS:  +1 309 205 3325 US \nInternational: https://duke.zoom.us/u/acGjMcvNR6 \nMeeting ID: 970 4889 0491 \nPasscode: 101816
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-march-29-2024-effect-of-a-multicomponent-intervention-to-improve-patient-access-to-kidney-transplant-and-living-kidney-donation-a-pragmatic-cluster-randomized-trial-amit-garg-md-ma/
CATEGORIES:Grand Rounds Event
END:VEVENT
END:VCALENDAR